AgeX Therapeutics, Inc. (AGE)

NYSEAMERICAN: AGE · IEX Real-Time Price · USD
0.385
-0.006 (-1.53%)
Dec 29, 2023, 4:00 PM EST - Market closed

Income Statement (Annual)

Millions USD. Fiscal year is Jan - Dec.
Year 2022202120202019201820172016
Revenue
0.030.140.361.731.41.41.67
Revenue Growth (YoY)
-76.39%-60.11%-79.11%23.78%-0.57%-15.73%-
Cost of Revenue
0.010.020.030.240.360.170.3
Gross Profit
0.020.130.341.481.031.241.36
Selling, General & Admin
5.976.716.728.145.653.875.62
Research & Development
1.031.463.715.95.835.788.48
Other Operating Expenses
-0.01-0.55-0.1100.8-1.750
Operating Expenses
6.987.6110.3314.0412.287.914.1
Operating Income
-6.96-7.49-10-12.56-11.25-6.66-12.74
Interest Expense / Income
3.341.10.4-0.0300.010.03
Other Expense / Income
0.170.090.47-0.52-3.74-0.12.73
Pretax Income
-10.46-8.68-10.87-12.01-7.5-6.58-15.49
Income Tax
0000.15000
Net Income
-10.46-8.68-10.87-12.15-7.5-6.58-15.49
Shares Outstanding (Basic)
38383837353129
Shares Outstanding (Diluted)
38383837353129
Shares Change
0.16%0.58%1.07%6.75%13.93%6.40%-
EPS (Basic)
-0.28-0.23-0.29-0.33-0.21-0.21-0.54
EPS (Diluted)
-0.28-0.23-0.29-0.33-0.21-0.21-0.54
Free Cash Flow
-5.94-7.86-7.84-10.8-8.02-6.29-8.45
Free Cash Flow Per Share
-0.16-0.21-0.21-0.29-0.23-0.20-0.29
Gross Margin
61.76%86.81%92.80%85.88%73.93%88.03%81.75%
Operating Margin
-20476.47%-5197.92%-2768.70%-726.79%-805.52%-474.57%-764.65%
Profit Margin
-30770.59%-6024.31%-3009.70%-703.36%-537.39%-468.66%-929.89%
Free Cash Flow Margin
-17467.65%-5454.86%-2170.91%-625.06%-574.21%-447.72%-507.20%
EBITDA
-7-7.45-9.21-11.08-6.97-5.89-14.62
EBITDA Margin
-20573.53%-5171.53%-2550.14%-641.44%-499.07%-419.23%-877.67%
Depreciation & Amortization
0.130.131.260.950.540.680.85
EBIT
-7.13-7.58-10.46-12.04-7.5-6.57-15.47
EBIT Margin
-20961.76%-5262.50%-2897.78%-696.47%-537.39%-467.81%-928.39%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).